These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 25139788)
1. PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models. Guillot C; Favaudon V; Herceg Z; Sagne C; Sauvaigo S; Merle P; Hall J; Chemin I BMC Cancer; 2014 Aug; 14():603. PubMed ID: 25139788 [TBL] [Abstract][Full Text] [Related]
2. A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia. Liu SK; Coackley C; Krause M; Jalali F; Chan N; Bristow RG Radiother Oncol; 2008 Aug; 88(2):258-68. PubMed ID: 18456354 [TBL] [Abstract][Full Text] [Related]
3. Protein expression of DNA damage repair proteins dictates response to topoisomerase and PARP inhibitors in triple-negative breast cancer. Boerner JL; Nechiporchik N; Mueller KL; Polin L; Heilbrun L; Boerner SA; Zoratti GL; Stark K; LoRusso PM; Burger A PLoS One; 2015; 10(3):e0119614. PubMed ID: 25774912 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Albert JM; Cao C; Kim KW; Willey CD; Geng L; Xiao D; Wang H; Sandler A; Johnson DH; Colevas AD; Low J; Rothenberg ML; Lu B Clin Cancer Res; 2007 May; 13(10):3033-42. PubMed ID: 17505006 [TBL] [Abstract][Full Text] [Related]
5. The poly(ADP-Ribose) polymerase inhibitor ABT-888 reduces radiation-induced nuclear EGFR and augments head and neck tumor response to radiotherapy. Nowsheen S; Bonner JA; Yang ES Radiother Oncol; 2011 Jun; 99(3):331-8. PubMed ID: 21719137 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma. Barazzuol L; Jena R; Burnet NG; Meira LB; Jeynes JC; Kirkby KJ; Kirkby NF Radiat Oncol; 2013 Mar; 8():65. PubMed ID: 23510353 [TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase inhibitors combined with external beam and radioimmunotherapy to treat aggressive lymphoma. Schaefer NG; James E; Wahl RL Nucl Med Commun; 2011 Nov; 32(11):1046-51. PubMed ID: 21956491 [TBL] [Abstract][Full Text] [Related]
8. Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles. Muñoz-Gámez JA; López Viota J; Barrientos A; Carazo Á; Sanjuán-Nuñez L; Quiles-Perez R; Muñoz-de-Rueda P; Delgado Á; Ruiz-Extremera Á; Salmerón J Liver Int; 2015 Apr; 35(4):1430-41. PubMed ID: 24821649 [TBL] [Abstract][Full Text] [Related]
10. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy. Lin L; Zhang YD; Chen ZY; Chen Y; Ren CP Tumour Biol; 2016 Sep; 37(9):12339-12346. PubMed ID: 27300349 [TBL] [Abstract][Full Text] [Related]
11. Acquired resistance to combination treatment with temozolomide and ABT-888 is mediated by both base excision repair and homologous recombination DNA repair pathways. Liu X; Han EK; Anderson M; Shi Y; Semizarov D; Wang G; McGonigal T; Roberts L; Lasko L; Palma J; Zhu GD; Penning T; Rosenberg S; Giranda VL; Luo Y; Leverson J; Johnson EF; Shoemaker AR Mol Cancer Res; 2009 Oct; 7(10):1686-92. PubMed ID: 19825992 [TBL] [Abstract][Full Text] [Related]
12. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. Peralta-Leal A; Rodríguez-Vargas JM; Aguilar-Quesada R; Rodríguez MI; Linares JL; de Almodóvar MR; Oliver FJ Free Radic Biol Med; 2009 Jul; 47(1):13-26. PubMed ID: 19362586 [TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) polymerase-1 regulates the mechanism of irradiation-induced CNE-2 human nasopharyngeal carcinoma cell autophagy and inhibition of autophagy contributes to the radiation sensitization of CNE-2 cells. Zhou ZR; Zhu XD; Zhao W; Qu S; Su F; Huang ST; Ma JL; Li XY Oncol Rep; 2013 Jun; 29(6):2498-506. PubMed ID: 23563481 [TBL] [Abstract][Full Text] [Related]
14. Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells. Alotaibi M; Sharma K; Saleh T; Povirk LF; Hendrickson EA; Gewirtz DA Radiat Res; 2016 Mar; 185(3):229-45. PubMed ID: 26934368 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitization effect of poly(ADP-ribose) polymerase inhibition in cells exposed to low and high liner energy transfer radiation. Hirai T; Shirai H; Fujimori H; Okayasu R; Sasai K; Masutani M Cancer Sci; 2012 Jun; 103(6):1045-50. PubMed ID: 22404155 [TBL] [Abstract][Full Text] [Related]
16. Update on hepatocellular carcinoma breakthroughs: poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy. Guillot C; Hall J; Herceg Z; Merle P; Chemin I Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):137-42. PubMed ID: 23953496 [TBL] [Abstract][Full Text] [Related]
17. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair. Löser DA; Shibata A; Shibata AK; Woodbine LJ; Jeggo PA; Chalmers AJ Mol Cancer Ther; 2010 Jun; 9(6):1775-87. PubMed ID: 20530711 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells. Feng X; Koh DW Int J Oncol; 2013 Feb; 42(2):749-56. PubMed ID: 23254695 [TBL] [Abstract][Full Text] [Related]
19. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells. Bridges KA; Toniatti C; Buser CA; Liu H; Buchholz TA; Meyn RE Oncotarget; 2014 Jul; 5(13):5076-86. PubMed ID: 24970803 [TBL] [Abstract][Full Text] [Related]
20. Parg deficiency confers radio-sensitization through enhanced cell death in mouse ES cells exposed to various forms of ionizing radiation. Shirai H; Fujimori H; Gunji A; Maeda D; Hirai T; Poetsch AR; Harada H; Yoshida T; Sasai K; Okayasu R; Masutani M Biochem Biophys Res Commun; 2013 May; 435(1):100-6. PubMed ID: 23624507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]